Torben Joergensen - Biotage Ab President and CEO

<div class='logoBackup' style='background:#FCD202;color: white;font-size:3em;;'>BIT</div>
BITGF -- USA Stock  

USD 12.25  0.00  0.00%

Mr. Torben Joergensen no longer serves as President and Chief Executive Officer of Biotage AB, effective as of November 6, 2019. He has held the position since April 27, 2006. He was Director of the Company since April 24, 2019. Prior to that, he held corresponding positions at Affibody, KaroBio and the Danish diagnostic company, DAKO
Age: 66  CEO Since 2019      
46 18 56 59 00
Jorgensen is Chairman of the Board of Micropos Medical AB and Atlas Antibodies AB, as well as Board Member of Intervacc. He holds a BS degree in Economics from Copenhagen Business School.

Management Efficiency

The company has return on total asset (ROA) of 10.56 % which means that it generated profit of $10.56 on every $100 spent on asset. This is normal as compared to the sector avarege. Similarly, it shows return on equity (ROE) of 25.39 % meaning that it generated $25.39 on every $100 dollars invested by stockholders.
The company has accumulated 12.31 M in total debt with debt to equity ratio (D/E) of 19.4 indicating the company may have difficulties to generate enough cash to satisfy its financial obligations. Biotage Ab Ord has Current Ratio of 2.51 suggesting that it is liquid and has the ability to pay its financial obligations in time and when they become due.

Similar Executives

Found 12 records

CEO Since

Cheol JungSK Innovation
Zhaoxi LuAlibaba Group Holding Limited
Yong ZhangAlibaba Group Holding Limited
Sundar PichaiAlphabet
Timothy CookApple
Charlotte HoggVisa
Tim CookApple
Larry PageAlphabet
Jun KimSK Innovation
Charles ScharfVisa
Satya NadellaMicrosoft Corporation

Entity Summary

Biotage AB , a life science company, provides solutions, knowledge, and experience in the areas of organic and analytical chemistry, as well as for industrial applications in the United States, Europe, Japan, China, and internationally. The company sells its products to pharmaceutical and biotechnical companies, contract research and manufacturing organizations, and academic institutions and commercial, hospitalbio-analytical, and forensic laboratories, as well as laboratories within food and environmental analysis. Biotage Ab is traded on BATS Exchange in USA.Biotage Ab Ord A [BITGF] is traded as part of a regulated electronic over-the-counter service offered by the NASD.

Biotage Ab Ord Leadership Team

Karolina Lawitz, Member of the Board of Directors
NilsOlof Bjork, Director
Yvonne Martensson, Director
Steve Jordan, Chief Scientific Officer
Love Amcoff, Director, Employee Representative
Anders Wikstrom, Vice President - Operations
Thomas Eklund, Member of the Board of Directors
Lars Backman, Vice President of Corporate Development
Rikke Rytter, Vice President Global Marketing
Anders Walldov, Member of the Board of Directors
Mark Bradley, Director
Ove Mattsson, Chairman of the Board of Directors
Cecilia Hallner, Global Human Resources Director
Peter Ehrenheim, Member of the Board of Directors
Torben Joergensen, President and CEO
Paul Belton, Vice President - Business Development
Malin Albertsson, Director, Employee Representative
Annika Gardlund, Director, Employee Representative
Erika Johnson, CFO

Stock Performance Indicators

Did you try this?

Run Earnings Calls Now


Earnings Calls

Check upcoming earnings announcements updated hourly across public exchanges
All  Next Launch Module

Biotage Ab Pair Correlation

Equities Pair Trading Analysis

Correlation analysis and pair trading evaluation for Biotage Ab and Facebook. Pair trading can be used as a hedging technique within a particular sector or industry or even over random equities to generate better risk-adjusted return
Run Pair Correlation  
Continue to Trending Equities. Please also try Equity Forecasting module to use basic forecasting models to generate price predictions and determine price momentum.